Central labs receive 300 cough syrup samples

NEW DELHI : Government laboratories have received around 300 cough syrup samples for quality testing after the embarrassment of toxic syrups causing deaths abroad.

Indian-made cough syrups have been linked to the death of dozens of children in Uzbekistan and Gambia, prompting the government to tighten the export policy for cough syrups. It is now mandatory to test before supplying to other countries.

As of 4 July, Central labs in Chennai, Mumbai, Kolkata, Ghaziabad (UP), Chandigarh, Gujarat and Jammu had received samples.

On the other hand, government labs in Karnataka, Kerala, Bhopal, Maharashtra, and Uttarakhand, Hyderabad and Guwahati are yet to receive any. The drug regulator has issued an alert to all manufacturers not to over-burden one particular lab for testing.

India, the largest provider of generic drugs globally, exported cough syrups worth $17.6 billion in 2022-23 as against $17 billion in 2021-22. India’s pharma export body Pharmexcil has over 2,000 manufacturers registered with it, and most are manufacturing cough syrups. Queries sent to the health ministry spokesperson did not elicit any response.

Related Posts

Six Women Develop Serious Complications After C-Section

Jaipur/Kota — In a serious medical incident that has raised concerns over patient safety at government facilities, six women who underwent caesarean section deliveries at Kota’s New Medical College Hospital developed…

Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

Jaipur:  Continuing its statewide anti-adulteration and food safety enforcement drive, the Food Safety Department Rajasthan conducted a major inspection and sampling operation at a pharma biological manufacturing unit located in…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Six Women Develop Serious Complications After C-Section

Six Women Develop Serious Complications After C-Section

Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

Indian Pharma Majors Plan to Invest in US

Indian Pharma Majors Plan to Invest in US

Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

Fake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED Probe

Fake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED Probe

A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental

A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental